|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Saxton RA and Sabatini DM: mTOR signaling
in growth, metabolism, and disease. Cell. 168:960–976.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Marenholz I, Zirra M, Fischer DF,
Backendorf C, Ziegler A and Mischke D: Identification of human
epidermal differentiation complex (EDC)-encoded genes by
subtractive hybridization of entire YACs to a gridded keratinocyte
cDNA library. Genome Res. 11:341–355. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fagerberg L, Hallström BM, Oksvold P,
Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S,
Danielsson A, Edlund K, et al: Analysis of the human
tissue-specific expression by genome-wide integration of
transcriptomics and antibody-based proteomics. Mol Cell Proteomics.
13:397–406. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jeng EE, Bhadkamkar V, Ibe NU, Gause H,
Jiang L, Chan J, Jian R, Jimenez-Morales D, Stevenson E, Krogan NJ,
et al: Systematic identification of host cell regulators of
legionella pneumophila pathogenesis using a genome-wide CRISPR
Screen. Cell Host Microbe. 26:551–563.e6. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wei YJ, Hu QQ, Gu CY, Wang YP, Han ZG and
Cai B: Up-regulation of NICE-3 as a novel EDC gene could contribute
to human hepatocellular carcinoma. Asian Pac J Cancer Prev.
13:4363–4368. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang W, Li A, Han X, Wang Q, Guo J, Wu Y,
Wang C and Huang G: DEPDC1 up-regulates RAS expression to inhibit
autophagy in lung adenocarcinoma cells. J Cell Mol Med.
24:13303–13313. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li A, Wang Q, He G, Jin J and Huang G: DEP
domain containing 1 suppresses apoptosis via inhibition of A20
expression, which activates the nuclear factor κB signaling pathway
in HepG2 cells. Oncol Lett. 16:949–955. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-Negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8(e82241)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A (eds): AJCC Cancer Staging Manual. 7th
edition. Springer, New York, NY, 2010.
|
|
15
|
Wei Y, Zou Z, Becker N, Anderson M,
Sumpter R, Xiao G, Kinch L, Koduru P, Christudass CS, Veltri RW, et
al: EGFR-mediated beclin 1 phosphorylation in autophagy
suppression, tumor progression, and tumor chemoresistance. Cell.
154:1269–1284. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Levine B and Kroemer G: Biological
functions of autophagy genes: A disease perspective. Cell.
176:11–42. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64.
2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chin YR and Toker A: Function of Akt/PKB
signaling to cell motility, invasion and the tumor stroma in
cancer. Cell Signal. 21:470–476. 2009.PubMed/NCBI View Article : Google Scholar
|
